New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Assessing clinical implementation of past standards for interpretation and reporting of sequence variants in cancer

Assessing clinical implementation of past standards for interpretation and reporting of sequence variants in cancer

by Association for Molecular PathologyAMP/ASCO/CAP Somatic Variants Guideline Implementation Survey—Selected Results. Panel A: Q1: Have you implemented the AMP/ASCO/CAP somatic variant classification
Oncology January 02,2024
Assessing clinical implementation of past standards for interpretation and reporting of sequence variants in cancer

Assessing clinical implementation of past standards for interpretation and reporting of sequence variants in cancer

by Association for Molecular PathologyAMP/ASCO/CAP Somatic Variants Guideline Implementation Survey—Selected Results. Panel A: Q1: Have you implemented the AMP/ASCO/CAP somatic variant classification
Oncology January 02,2024
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

by Impact JournalsMechanisms of SCR resistance and characterization of the CD20 negative MCL cell lines 353. Credit: LeBlanc et al,Oncotarget(2022). DOI: 10.18632/oncotarget.28258A new res
Oncology January 02,2024
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

by Impact JournalsMechanisms of SCR resistance and characterization of the CD20 negative MCL cell lines 353. Credit: LeBlanc et al,Oncotarget(2022). DOI: 10.18632/oncotarget.28258A new res
Oncology January 02,2024
Turncoat T cells: When exhausted, cancer-fighting T cells may switch sides

Turncoat T cells: When exhausted, cancer-fighting T cells may switch sides

byUniversity of PittsburghGreg Delgoffe, Ph.D., associate professor of immunology at Pitt’s School of Medicine and director of the Tumor Microenvironment Center at UPMC Hillman Cancer Center. Cr
Oncology January 02,2024
Turncoat T cells: When exhausted, cancer-fighting T cells may switch sides

Turncoat T cells: When exhausted, cancer-fighting T cells may switch sides

byUniversity of PittsburghGreg Delgoffe, Ph.D., associate professor of immunology at Pitt’s School of Medicine and director of the Tumor Microenvironment Center at UPMC Hillman Cancer Center. Cr
Oncology January 02,2024
EU approves treatment for prostate cancer

EU approves treatment for prostate cancer

Prostate cancer cells. Credit: NIH Image GalleryThe European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.The
Oncology January 02,2024
EU approves treatment for prostate cancer

EU approves treatment for prostate cancer

Prostate cancer cells. Credit: NIH Image GalleryThe European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.The
Oncology January 02,2024
Invasive breast cancer risk down for female child cancer survivors

Invasive breast cancer risk down for female child cancer survivors

For childhood cancer survivors, the rates of invasive breast cancer have decreased over time, according to a study published online Oct. 13 inJAMA Oncology.Tara O. Henderson, M.D., M.P.H., from
Oncology January 02,2024
Invasive breast cancer risk down for female child cancer survivors

Invasive breast cancer risk down for female child cancer survivors

For childhood cancer survivors, the rates of invasive breast cancer have decreased over time, according to a study published online Oct. 13 inJAMA Oncology.Tara O. Henderson, M.D., M.P.H., from
Oncology January 02,2024
Too often, women aren't told of sexual side effects of cancer treatments

Too often, women aren't told of sexual side effects of cancer treatments

by Cara MurezWhen a man has cancer in an area that affects sexual function, his doctor is likely to discuss it with him.But the same is not true for a woman who has cancer in a sex organ, according to
Oncology January 02,2024
Too often, women aren't told of sexual side effects of cancer treatments

Too often, women aren't told of sexual side effects of cancer treatments

by Cara MurezWhen a man has cancer in an area that affects sexual function, his doctor is likely to discuss it with him.But the same is not true for a woman who has cancer in a sex organ, according to
Oncology January 02,2024
Female cancer survivors experience accelerated declines in physical function

Female cancer survivors experience accelerated declines in physical function

by Lori SolomonFemale survivors of cancer experience accelerated declines in physical function after diagnosis versus matched controls, according to a study published online Jan. 19 inJAMA Oncol
Oncology January 02,2024
Female cancer survivors experience accelerated declines in physical function

Female cancer survivors experience accelerated declines in physical function

by Lori SolomonFemale survivors of cancer experience accelerated declines in physical function after diagnosis versus matched controls, according to a study published online Jan. 19 inJAMA Oncol
Oncology January 02,2024
Agronomists save tomatoes from toxic aluminum with melatonin

Agronomists save tomatoes from toxic aluminum with melatonin

byRUDN UniversityCredit:South African Journal of Botany(2023). DOI: 10.1016/j.sajb.2023.09.031RUDN University agronomists and colleagues from China and Iran have helped tomatoes cope
Oncology January 02,2024
Agronomists save tomatoes from toxic aluminum with melatonin

Agronomists save tomatoes from toxic aluminum with melatonin

byRUDN UniversityCredit:South African Journal of Botany(2023). DOI: 10.1016/j.sajb.2023.09.031RUDN University agronomists and colleagues from China and Iran have helped tomatoes cope
Oncology January 02,2024
Rural residence tied to poorer adherence to radiation treatment for cancer

Rural residence tied to poorer adherence to radiation treatment for cancer

Rural residence is associated with both radiation treatment (RT) nonadherence and poorer overall survival among cancer patients, according to a study recently published in theInternational Journ
Oncology January 02,2024
Rural residence tied to poorer adherence to radiation treatment for cancer

Rural residence tied to poorer adherence to radiation treatment for cancer

Rural residence is associated with both radiation treatment (RT) nonadherence and poorer overall survival among cancer patients, according to a study recently published in theInternational Journ
Oncology January 02,2024
Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

by Ken Kingery,Duke UniversityCredit: Unsplash/CC0 Public DomainBiomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mous
Oncology January 02,2024
Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

by Ken Kingery,Duke UniversityCredit: Unsplash/CC0 Public DomainBiomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mous
Oncology January 02,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com